What You Should Know
The Funding: Malama Health, a maternal health company, has closed an oversubscribed $9.2M seed round led by Acumen America with participation from Wisdom Ventures, Capital F, and Coyote Ventures, alongside angels from the company's pre-seed round. The Capital Stack: Uniquely, the round is not purely venture capital. It includes a $2.3M NIH grant and over $1M in California state funding, signaling deep alignment across federal, state, and private stakeholders.The
Read More
Femtech
Maven Clinic Launches Direct-to-Consumer Platform Nationwide Featuring GLP-1 and Hormone Care
What You Should Know
The Launch: Maven Clinic, previously known for its massive enterprise footprint, has opened the beta waitlist for its new direct-to-consumer (DTC) platform, making its virtual care model available to women nationwide regardless of employer coverage.The Market Context: For the last decade, Maven focused primarily on B2B partnerships, securing over 2,300 employer and health plan clients and covering 28 million lives.The Clinical Pillars: The DTC platform features three core
Read More
Sword Health Evolves ‘Bloom’ into an AI Operating System for Women’s Health
What You Should Know
The Evolution: Sword Health is expanding its highly successful Bloom product from a condition-specific pelvic care solution into a comprehensive, life-stage-based women's health platform.The Clinical Scope: The platform now provides end-to-end support across a woman's entire lifespan, covering fertility and preconception, pregnancy, postpartum recovery, menopause, and persistent pelvic symptoms.The Menopause Anchor: To anchor the expansion, Bloom is launching a
Read More
Maven Clinic and Color Health Partner to Expand Virtual Oncofertility Services
What You Should Know
The Partnership: Maven Clinic, the unicorn virtual clinic for women’s health, has partnered with Color Health, the leader in virtual cancer care, to launch a specialized "oncofertility" program.The Gap: With cancer rates rising among young adults (80,000 U.S. diagnoses annually), fewer than 50% of patients report discussing fertility preservation with their oncologist before starting treatments like chemo or radiation that could leave them infertile.The Solution: The
Read More
Mira Announces Integration with Oura Ring to Combine Hormone Data with Sleep and Temperature Trends
What You Should Know
The Integration: Mira, the leader in at-home lab-grade hormone testing, has launched a direct integration with ŌURA, the maker of the popular smart ring.The Data Flow: Users can now view Oura’s biometric data—specifically sleep, readiness, and temperature trends—directly inside the Mira app, alongside their hormone concentrations.The Goal: The partnership aims to provide "context" to women's health data. By correlating a drop in sleep quality with a specific hormonal
Read More
The “Unicorn” of Menopause: Midi Health Hits $1B Valuation with $100M
What You Should Know
The Milestone: Midi Health has raised a $100M Series D, propelling its valuation over $1 billion. This "unicorn" status marks a pivotal moment for the women's health sector, which has historically been underfunded.The Pivot: While founded on menopause care, Midi is using this capital to expand into "lifelong care," addressing gaps in cardiology, obesity, and longevity for women.The Scale: The platform now serves 25,000 patients per week and covers 45 million women via
Read More
Wisp Acquires TBD Health to Build the “Hybrid” Future of Sexual Wellness
What You Should Know
The News: Wisp, the largest women’s telehealth company in the U.S., has acquired TBD Health, marking its first strategic acquisition and expanding its reach from Direct-to-Consumer (DTC) to enterprise and hybrid care. Financial details of the acquisition were not disclosed. The Gap: The deal targets a critical failure in public health: despite availability, only ~25% of eligible Americans are enrolled in PrEP (HIV prevention), with women being significantly
Read More
WHAM 2026: The Economic Case for Women’s Health Investment
What You Should Know:
- The 2026 WHAM Investment Report, released at the 44th Annual JPMorgan Healthcare Conference, establishes women’s health as a high-growth precision medicine category.
- Redefining the market beyond reproductive care, the report provides a roadmap for capital allocation into conditions that affect women exclusively, differently, or disproportionately. It features six in-depth case studies demonstrating real-world commercial success and durable long-term
Read More
Why Axena Health and Mayo Clinic are Building an AI-Driven Future for Pelvic Health
What You Should Know
- Axena Health has announced a major expansion of its collaboration with Mayo Clinic to develop a new, AI-integrated solution for women with pelvic floor disorders.
- Building on their initial 2025 partnership, the new initiative aims to leverage Mayo Clinic’s clinical expertise to create personalized care pathways that improve treatment adherence for conditions like urinary incontinence and overactive bladder (OAB).
Solving the Adherence Gap: AI as a Clinical
Read More
The Seamless Scan: Why Interoperability is the New Standard for OB-GYN Ultrasound Reporting in 2026
Increasing patient volumes calls for strengthened streamlined processes like never before.
With vast patient data coming from various platforms, tools and systems, the means of connectivity and pooling this information has become a critical factor to successful patient experiences.Today’s healthcare landscape needs a well blended and meticulously integrated system of patient data across all administrative data portals and platforms.
This is why in modern medical practice,
Read More
